ArticlePDF Available

NOONAN SYNDROME – CASE REPORT

Authors:

Abstract and Figures

Noonan Syndrome is a rare, autosomal dominant disorder characterized by short stature, facial abnormalities, congenital heart defects and urogenital malformations. Ocular changes occur in 95% of patients and usually include hypertelorism, ptosis, refractive errors, strabismus, amblyopia, rarely nystagmus, colobomas, cataracts, optic nerve drusen. Case report: We present a case of a boy, 10 months old, referred by the pediatrician because of strabismus. During the general examination of the head and face, we noted that the ears were low-set, and the lower jaw was slightly smaller. Ophthalmological examination revealed hypertelorism, left eye esotropia, hyperopia, and optic disc pit. Other associated malformations were: dilatation of both pyelons, cryptorchidism, pulmonary stenosis. Genetic analysis confirmed the diagnosis of Noonan syndrome. The variety of clinical manifestations of this syndrome indicates that a multidisciplinary approach is necessary for diagnosis, treatment, and follow-up of these patients.
Content may be subject to copyright.
www.medfak.ni.ac.rs/amm
54
Case report UDC: 616-007-053.2-071:617.7
doi:10.5633/amm.2014.0209
NOONAN SYNDROMECASE REPORT
Milena Vujanović1, Gordana Stanković-Babić1,2, Sonja Cekić1,2
Noonan Syndrome is a rare, autosomal dominant disorder characterized by short
stature, facial abnormalities, congenital heart defects and urogenital malformations.
Ocular changes occur in 95% of patients and usually include hypertelorism, ptosis,
refractive errors, strabismus, amblyopia, rarely nystagmus, colobomas, cataracts, optic
nerve drusen.
Case report: We present a case of a boy, 10 months old, referred by the
pediatrician because of strabismus. During the general examination of the head and
face, we noted that the ears were low-set, and the lower jaw was slightly smaller.
Ophthalmological examination revealed hypertelorism, left eye esotropia, hyperopia, and
optic disc pit. Other associated malformations were: dilatation of both pyelons,
cryptorchidism, pulmonary stenosis. Genetic analysis confirmed the diagnosis of Noonan
syndrome.
The variety of clinical manifestations of this syndrome indicates that a
multidisciplinary approach is necessary for diagnosis, treatment, and follow-up of these
patients. Acta Medica Medianae 2014;53(2):54-56.
Key words: congenital anomalies, ocular manifestations, systemic manifestations
Clinic for Eye Diseases, Clinical Center Niš, Serbia1
Univers ity of Niš Facult y of Medicine, Serbia2
Contact: Milena Vujanović
Clinic for Eye Diseases, Clinical Cente r Niš
Bul. Dr Zorana Đinđića 48, 18000 Niš, Serbia
E-mail: milenavujanovic@gmail.com
Introduction
Noonan Syndrome (NS) is a rare autosomal
dominant inherited disorder. It was known under
various names such as male Turner's syndrome,
Turner-like syndrome or Turner syndrome with
normal karyotype, when in 1963 Dr. Jacqueline
Noonan defined these changes as a specific
syndrome which was named after her (1). The
incidence of NS is different and ranges from 1/1000
to 1/2500 live births (2,3).
The disease is characterized by short statue,
facial abnormalities, congenital heart defects and
urogenital malformations. Less frequently the
disease may be accompanied by delayed psycho-
motor development. Also, in these patients,
especially in childhood, disorders of coagulation
factors (VIII, XI, XII) and thrombocytopenia are
common. The hearing loss may also occur. In a
small percentage of subjects, pigmentation
disorders such as naevi, cafe-au-lait spots and
lentigo occur. It is of great importance to mention
that in these patients, there is a high incidence of
lesions of the eye, usually hypertelorism, down-
slanting palpebral fissures, epicanthic folds, ptosis,
refractive errors, strabismus, amblyopia, nys-
tagmus, and rarely cataract, colobomas, and
keratoconus (4-6).
We present a case of a boy, 10 months old,
sent by the pediatrician because of strabismus.
Ophthalmological examination showed: hyper-
telorism, down-slanting palpebral fissures, left eye
esotropia (angle of deviation 15 Δd). Ocular
motility, as well as convergence, were preserved in
all directions. The child followed a toy and a light
source in all directions (Figure 1). Anterior segment
examination was normal and the value of
intraocular pressure/IOP was 10mmHg. After
performing the indirect ophthalmoscopy (indirect
ophthalmoscope-Heine 500, Germany) we found
that retinal blood vessel network was completely
developed and the bilateral presence of optic disc
pits was diagnosed. During cycloplegia, achieved by
topical administration of Sol. Atropin 0,25%, mild
hypermetropia (+1,0Dsph) was found. Ultrasound
examination of the eyes was performed.
(Ultrasound A/ B Scanner UD-6000, Tomey, A-
scan, 10MHz, 5.3 mm). Axial length (Lax) was
measured on both eyes, 20.95 mm right eye and
OS 20.98 mm left eye. Ultrasound B-scan confirmed
the presence of optic disc pit (Figure 2 and 3).
Visual evoked potential in the right eye was normal,
but on the left it was less defined, with prolonged
latency and lower amplitude.
Figure 1.
Acta Medica Medianae 2014, Vol.53(2) Noonan syndromecase report
55
Table 1. Scoring system for diagnosis of NS
Present changes
A=major
B=minor
Face
Typical face dysmorphology
Suggestive face dysmorphology
Heart
Pulmonary valve stenosis,
cardiomiopathy
Other defect
Body height
<P3*
<P10*
Thorax
Pectus carinatun/excavatum
Broad thorax
Family history First degree relative with definite NS
First degree relative with suggestive
NS
Other
Mental retardation, cryptorchidism
and lymphatic dysplasia
Milder forms of these changes
* P3 and P10-related measures height by age (normal range P3-P97)
Definitive NS: 1 "A" plus other major sign or two minor signs; 1 "B" plus two major signs or three minor signs
Figure 2. Eho OD (Ultrasound A / B Scanner UD-6000,
Tomey, A-scan, 10MHz, 5.3 mm)
Figure 3. Eho OS (Ultrasound A / B Scanner UD-6000,
Tomey, A-scan, 10MHz, 5.3 mm)
General examination of the head and neck
showed that the ears were low-set, irregularly
shaped, posteriorly rotated, with a thick helix, high
arched palate, micrognathia.
From the child’s medical documentation on
the previous treatment we found out that it was a
premature child (GS 36 weeks, TM 2500g) which
suffered from respiratory distress syndrome,
intracranial hemorrhage of the first degree,
dilatation of both renal pyelons, migratory testis,
and stenosis a. pulmonalis. Because of hypotonia,
the child was prescribed an adequate physical
treatment by a physiatrist.
However, due to all these changes, the child
was referred to a geneticist. A normal male
karyotype type (46 XY) was determined, but the
clinical examination of the child pointed to Noonan
syndrome. Genetic testing of the child and parents
confirmed PTPN11 gene mutation on chromosome
12.
Discussion
Syndrome Noonan includes a very hetero-
geneous group of multiple congenital anomalies,
which are easy to recognize clinically. However,
due to a various degree of manifestations of
these changes, a scoring system was created to
help the diagnostic process (Table 1) (7).
This scoring system is very important for
early recognition of this syndrome and appro-
priate treatment of numerous anomalies.
As the child grows, the clinical diagnosis is
more and more difficult as the changes are not
easily noticed, and the risk of consequences of
untreated anomalies such as cardiac anomaly,
cryptorchidism, chest wall deformities, coagulation
disorders, slow psychomotor development, strabi-
smus and amblyopic increase during the growth.
The ocular abnormalities in Noonan syn-
drome are very common and are found in about
95% of cases (6,8). The most common are
refractive errors (61%), strabismus (48-63%),
and amblyopia (33%) (5,8). Coloboma and other
malformations of the retina occur very rarely
(10%) and are usually associated with PTPN11
gene mutations (8,9). Given such a high inci-
dence of ocular changes, the ophthalmologist can
be a very important link in the diagnostic chain,
as was the case with the patient we presented.
Even though the diagnosis of Noonan
syndrome can be established on the basis of the
clinical picture, it is important to do genetic
testing whenever possible. In approximately 50%
of these patients there is a mutation of PTPN11
gene on chromosome 12. This gene is respon-
sible for the synthesis of the enzyme tyrosine
phosphatase SHP-2. It is an intracellular signal
for initiating a cascade reaction growth factor
receptor, cytokines and hormones that regulate
the processes of growth and development (10,11).
Noonan syndrome mostly occurs on a sporadic
Noonan syndromecase report Milena Vujanović et al.
56 This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) Licence
basis or in a pattern consistent with autosomal
dominant inheritance, with a predominance of
maternal transmission (11,12). De novo mutation
of PTPN11 is possible in sporadic cases of Noonan
syndrome and is predominantly of paternal
origin, as was the case in the present patient.
However, there is evidence for a rare autosomal
recessive form of the disease (12).
Conclusion
This rare syndrome is characterized by a
very heterogeneous group of changes in various
organs, which further requires a multidisciplinary
approach in order to provide early diagnosis and
treatment of numerous malformations in these
patients.
References
1. Noonan JA, Ehmke DA. Associated non-cardiac
malformations in children with Congenital heart
disease. J Paed 1963;63:468-70.
2. Allanson JE. Noonan syndrome.J Med Genet
1987;24:9-13. [Crossref][Pubmed]
3. Sharland M, Burch M, Patton MA. A clinical study of
Noonan syndrome.Arch Dis Child 1992; 67: 178-83.
[Crossref][Pubmed]
4. Lee NB, Kelly L, Sharland M. Ocular manife stations
of Noonan syndrome. Eye 1992;6:328-34. [Crossref]
[Pubmed]
5. Reynolds DJ, Rubin SE, Fox J, Kodsi SR. Ocular
manifestations of Noonan syndrome in the pediatric
patient. J AAPOS 2004; 8: 282-3. [Crossref] [Pubmed]
6. Randolph JC, Sokol JA, Lee HB, Nunery WR. Orbital
manifestation of Noonan Syndrome. Ophthal Plast
Reconstr Surg 2011;27(6):160-3. [Crossref] [Pubmed]
7. van der Burgt I, Berends E, Lommen E, van
Beersum S, Hamel B, Mariman E. Clinical and
molecular studies in a large Dutch family with
Noonan syndrome. Am J Med Genet 1994;53: 187-
91. [Crossref][Pubmed]
8. Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall
B, Pierpont ME,et al. Noonan Syndrome: Clinical
features,Diagnosis, and Management Guidelines.
Pediatrics 2010; 126: 746-59. [Crossref][Pubmed]
9. van der Burgt I. Noonan syndrome. Orphanet J Rare
Dis 2007;2:4. [Crossref][Pubmed]
10. Neel BG, Gu H, Pao L.The 'Shp'ing news: SH2
domain-containing tyrosine phosphatases in cell
signaling. Trends. Biochem Sci 2003; 28:284-93.
[Crossref][Pubmed]
11. Tartaglia M, Cordeddu V, Chang H, Shaw A, Kalidas
K, Crosby A, et al.Paternal germline origin and sex-
ratio distortion in transmission of PTPN11 mutations
in Noonan syndrome. Am J Hum Genet 2004;75:492-
7. [Crossref] [Pubmed]
12. Tartaglia M, Gelb BD. Noonan syndromeand related
disorders:genetics and pathogenesis. Ann Rey
Genomics Hum Genet 2005;6:45-68. [Crossref]
[Pubmed]
SYNDROMA NOONAN – PRIKAZ BOLESNIKA
Milena Vujanović, Gordana Stanković-Babić, Sonja Cekić
Nunanov sindrom je retka autozomalno dominantno nasledna bolest, koja se
karakteriše niskim rastom, abnormalnostima lica, urođenim promenama na srcu i
urogenitalnom traktu. Promene na oku javljaju se kod 95% ovih bolesnika i najčešće su to
hipertelorizam, ptoza, refrakcione anomalije, strabizam, ambliopija, ređe nistagmus,
kolobomi, katarakta, druze papile vidnog živca.
Prikazujemo slučaj dečaka starog 10 meseci, upućenog od strane pedijatra zbog
skretanja levog oka. Opštim pregledom glave i lica primećeno je da su uši niže postavljene,
a donja vilica nešto manja. Oftalmološkim pregledom nađen je hipertelorizam, esotropija
levog oka, hipermetropija, anomalija optičkog diska po tipu jamice. Pregledom
dokumentacije deteta saznajemo da se radi o prevremeno rođenom detetu, koje je imalo
respiratorni distres sindrom, intrakranijalne hemoragije, dilataciju oba pijelona, migratorni
testis, stenozu a.pulmonalis. Konsultativnim pregledom genetičara potvrđena je dijagnoza
sindroma Noonan.
Raznolikost kliničkih manifestacija ovog sindroma ukazuje na neophodnost
multidisciplinarnog pristupa kako u otkrivanju tako i u kasnijem lečenju i praćenju ovih
bolesnika. Acta Medica Medianae 2014;53(2):54-56.
Ključne reči: kongenitalne anomalije, očne manifestacije, sistemske manifestacije
... The scoring system is important for early recognition and specific treatment. However, despite the presence of the scoring system, performing genetic testing, whenever possible, is important (10). The diagnosis of a genetic mutation allows the clinician to predict the severity of cardiac abnormalities, patient's evolution, as well as overall prognosis according to the cardiovascular disease severity. ...
Article
Full-text available
Introduction Noonan syndrome (NS) is a dominant autosomal disease, caused by mutations in genes involved in cell differentiation, growth and senescence, one of them being RAF1 mutation. Congenital heart disease may influence the prognosis of the disease. Case presentation We report a case of an 18 month-old female patient who presented to our institute at the age of 2 months when she was diagnosed with obstructive hypertrophic cardiomyopathy, pulmonary infundibular and pulmonary valve stenosis, a small atrial septal defect and extrasystolic arrhythmia. She was born from healthy parents, a non-consanguineous marriage. Due to suggestive phenotype for NS molecular genetic testing for RASopathies was performed in a center abroad, establishing the presence of RAF-1 mutation. Following rapid progression of cardiac abnormalities, the surgical correction was performed at 14 months of age. In the early postoperative period, the patient developed episodes of sustained ventricular tachycardia with hemodynamic instability, for which associated treatment was instituted with successful conversion to sinus rhythm. At 3-month follow-up, the patient was hemodynamically stable in sinus rhythm. Conclusions The presented case report certifies the importance of recognizing the genetic mutation in patients with NS, which allows predicting the severity of cardiac abnormalities and therefore establishing a proper therapeutic management of these patients.
Article
Purpose Demonstrating the clinical utility of genetic testing is fundamental to clinical adoption and reimbursement, but standardized definitions and measurement strategies for this construct do not exist. The Clinician-reported Genetic testing Utility InDEx (C-GUIDE) offers a novel measure to fill this gap. This study assessed its validity and inter-rater reliability. Methods Genetics professionals completed C-GUIDE after disclosure of test results to patients. Construct validity was assessed using regression analysis to measure associations between C-GUIDE and global item scores as well as potentially explanatory variables. Inter-rater reliability was assessed by administering a vignette-based survey to genetics professionals and calculating Krippendorff’s α. Results On average, a 1-point increase in the global item score was associated with an increase of 3.0 in the C-GUIDE score (P < .001). Compared with diagnostic results, partially/potentially diagnostic and nondiagnostic results were associated with a reduction in C-GUIDE score of 9.5 (P < .001) and 10.2 (P < .001), respectively. Across 19 vignettes, Krippendorff’s α was 0.68 (95% CI: 0.63-0.72). Conclusion C-GUIDE showed acceptable validity and inter-rater reliability. Although further evaluation is required, C-GUIDE version 1.2 can be useful as a standardized approach to assess the clinical utility of genetic testing.
Article
Full-text available
Purpose: To report a case of Noonan syndrome with multiple lentigines with unusual ocular features. Methods: The authors describe a case of a Seven-year-old girl with Noonan syndrome with multiple lentigines and anomalous optic discs. Results: A Seven-year-old girl with genetically proven Noonan syndrome with multiple lentigines (PTPN11 gene mutation) and anomalous optic discs was referred for treatment of persistent macular detachment after 1 year of conservative follow up. The right eye demonstrated an optic disc coloboma with best-corrected visual acuity of 20/32, the left eye demonstrated an optic disc pit with serous macular detachment (best-corrected visual acuity 20/50 - 20/80). Optical coherence tomography demonstrated a neurosensory detachment. 25 gauge pars plana vitrectomy was performed with posterior hyaloid detachment, drainage over disc pit area and SF6 20% gas tamponade. Surgery resulted in subretinal fluid reduction and improvement of visual acuity to 20/32. Conclusion: A case of Noonan syndrome with multiple lentigines with optic disc coloboma in the right eye and optic disc pit with related maculopathy in the left eye. To the authors' knowledge, this is the first reported case describing the association of Noonan syndrome with multiple lentigines and congenital optic disc anomalies. Optic disc pit maculopathy was managed surgically due to its longstanding nature with deteriorating visual acuity.
Article
Full-text available
Noonan syndrome (NS) is a rare genetic disorder, which may occur as sporadic or inherited as autosomal dominant or recessive trait. It is a multifactorial condition that is characterized by a series of congenital malformations including facial anomalies, post-natal growth development, webbing of neck, pulmonary stenosis and undescended testicles in boys. NS can be confirmed genetically by the presence of any of the known mutations. However, despite identification of fourteen causative genes, the absence of a known mutation will not exclude the diagnosis, as there are more undiscovered genes that cause NS. Thus, the diagnosis of NS is still based on clinical features. The present report describes a case of this syndrome without cardiac abnormalities but with characteristic bilateral toe walking.
Article
Noonan syndrome describes a rare multisystem condition that manifests with Turner syndrome phenotype combined with numerous systemic and facial characteristics. The most common systemic findings include cardiac defects, short stature, chest deformity, hearing loss, and bleeding diatheses. Patients with Noonan syndrome are also at a greater risk of developing various types of malignancies. Facial characteristics of Noonan syndrome consist of broad forehead, low-set ears, short and webbed neck, and low hairline. External ocular findings include hypertelorism, ptosis, epicanthal folds, antimongoloid slant, downward-sloping palpebral fissures, and malar flattening. In this case series and review of the literature, the authors present 2 cases of Noonan syndrome that embody the diverse spectrum of orbital manifestations associated with this rare disorder. The first case demonstrates more profound orbital pathology, including bilateral orbital giant cell reparative granulomas, proptosis, hypertelorism, shallow orbits, upper eyelid ptosis, and lower eyelid retraction. The second case displays classic Turner-syndrome-like facial characteristics including a broad forehead with low hairline, low-set ears, and short and webbed neck. Orbital findings were subtle and consisted of bilateral lower eyelid retraction and shallow orbits. In conclusion, Noonan syndrome is a rare congenital disorder with a wide spectrum of clinical findings. Various intraorbital and extraorbital tumors may occur in patients with Noonan syndrome, with giant cell reparative granuloma being the most commonly encountered. In patients with orbital tumors and eyelid retraction, the authors describe successful treatment through decompression, tumor extraction, and lower eyelid retractor release. Patients who present with ocular irritation and exposure due to less severe lower eyelid malposition may be successfully treated with lower eyelid retraction repair combined with lateral internal tarsoconjunctival tarsorrhaphy.
Article
Noonan syndrome (NS) is a common, clinically and genetically heterogeneous condition characterized by distinctive facial features, short stature, chest deformity, congenital heart disease, and other comorbidities. Gene mutations identified in individuals with the NS phenotype are involved in the Ras/MAPK (mitogen-activated protein kinase) signal transduction pathway and currently explain ∼61% of NS cases. Thus, NS frequently remains a clinical diagnosis. Because of the variability in presentation and the need for multidisciplinary care, it is essential that the condition be identified and managed comprehensively. The Noonan Syndrome Support Group (NSSG) is a nonprofit organization committed to providing support, current information, and understanding to those affected by NS. The NSSG convened a conference of health care providers, all involved in various aspects of NS, to develop these guidelines for use by pediatricians in the diagnosis and management of individuals with NS and to provide updated genetic findings.
Article
Noonan syndrome is a genetic condition inherited in an autosomally dominant manner, characterised by congenital heart disease, short stature, abnormal facies and the somatic features of Turner's syndrome, but a normal Karyotype. The ophthalmological and orthoptic findings on 58 patients with Noonan syndrome are reported. External features were hypertelorism (74%), downward sloping palpebral apertures (38%), epicanthic folds (39%) and ptosis (48%). The orthoptic examination revealed strabismus in 48%, refractive errors in 61%, amblyopia in 33%, and nystagmus in 9% of cases. Sixty-three per cent of cases had anterior segment changes consisting of: Prominent corneal nerves (46%), anterior stromal dystrophy (4%), cataracts (8%) and panuveitis (2%). Fundal changes occurred in 20% of the study group, including optic nerve head drusen, optic disc hypoplasia, colobomas and myelinated nerves. Forty-seven per cent required non surgical treatment and a further 16% had undergone surgery for strabismus or ptosis. Only three patients had no visual defects. With such a high incidence of ophthalmic abnormalities it is clearly important that children with Noonan syndrome are screened by an ophthalmologist at an early age.
Article
Clinical details are presented on 151 individuals with Noonan syndrome (83 males and 68 females, mean age 12.6 years). Polyhydramnios complicated 33% of affected pregnancies. The commonest cardiac lesions were pulmonary stenosis (62%), and hypertrophic cardiomyopathy (20%), with a normal echocardiogram present in only 12.5% of all cases. Significant feeding difficulties during infancy were present in 76% of the group. Although the children were short (50% with a height less than 3rd centile), and underweight (43% with a weight less than 3rd centile), the mean head circumference of the group was on the 50th centile. Motor milestone delay was usual, the cohort having a mean age of sitting unsupported of 10 months and walking of 21 months. Abnormal vision (94%) and hearing (40%) were frequent findings, but 89% of the group were attending normal primary or secondary schools. Other associations included undescended testicles (77%), hepatosplenomegaly (50%), and evidence of abnormal bleeding (56%). The mean age at diagnosis of Noonan syndrome in this group was 9.0 years. Earlier diagnosis of this common condition would aid both clinical management and genetic counselling.
Article
We describe the largest Noonan syndrome (NS) family reported to date. The manifestations of the affected relatives are discussed. In the absence of a biochemical marker NS is still a clinical diagnosis. The diagnostic criteria that were used are presented compared with other published criteria for diagnosing NS. The large size of this family enabled us to test the possible involvement of candidate regions by multipoint linkage analysis. Both the region surrounding the NF1 locus on chromosome 17 and the proximal part of chromosome 22 could be excluded. Since NS may well be heterogeneous, the use of such a large family in linkage studies of NS should prove indispensable.
Article
Src homology-2 (SH2) domain-containing phosphatases (Shps) are a small, highly conserved subfamily of protein-tyrosine phosphatases, members of which are present in both vertebrates and invertebrates. The mechanism of regulation of Shps by ligand binding is now well understood. Much is also known about the normal signaling pathways regulated by each Shp and the consequences of Shp deficiency. Recent studies have identified mutations in human Shp2 as the cause of the inherited disorder Noonan syndrome. Shp2 mutations might also contribute to the pathogenesis of some leukemias. In addition, Shp2 might be a key virulence determinant for the important human pathogen Helicobacter pylori. Despite these efforts, however, the key targets of each Shp have remained elusive. Identifying these substrates remains a major challenge for future research.
Article
Noonan syndrome is a rare syndrome with both ocular findings and multiple organ involvement. We retrospectively identified all of the pediatric patients with Noonan syndrome seen at our institution and reviewed the ocular findings to determine specific ocular manifestations in pediatric Noonan syndrome patients.